Esubalew Assefa

Dr. Esubalew Assefa is a Health Economist at the Health Economics and Policy Research Unit (HEPRU) and Pragmatic Clinical Trials Unit (PCTU) within Queen Mary University of London's Centre for Evaluation and Methods (CEM). He also serves as a methods advisor (health economics) for the NIHR Research Support Service (RSS) Hub, collaborating with Imperial College London and other institutions. Previously, he was a postdoctoral fellow at the Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), focusing on multimorbidities in low- and middle-income countries and enhancing research-to-policy translation. His research interests include outcome assessment, economic evaluation, health technology assessment, policy evaluation, evidence synthesis, and healthcare financing. Dr. Assefa has experience in teaching economics and program management in higher education.

Research Trends: His work spans global health challenges, particularly in Ethiopia and Southeast Asia, addressing mental health interventions, neglected tropical diseases, healthcare access disparities, and pandemic socioeconomic impacts. He emphasizes evidence-based approaches to policy and sustainable academic partnerships. Recent studies include randomized trials on depression detection, cost-effectiveness analyses of mental healthcare models, and scoping reviews on research uptake in low-resource settings.

Advising & Grants: While no specific grants or trainees are listed, his advisory role in the NIHR RSS Hub indicates involvement in methodological guidance for health economics research. Collaborations with institutions like CDT-Africa highlight his commitment to translational research in global health contexts.

Labs/Teams: Affiliated with HEPRU, PCTU, and the Wolfson Institute of Population Health, he contributes to multidisciplinary teams focused on population health challenges and clinical trial methodologies.